Loading...

Richard Price, MD

Address1001 Potrero Ave, SFGH 1
San Francisco CA 94110
Phone415-206-4487
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Compartmentalized CSF viral escape and the CNS HIV reservoir
    NIH/NINDS R01NS094067Sep 30, 2015 - Jul 31, 2020
    Role: Principal Investigator
    Defining CNS HIV Infection in Treated Patients: Foundation for Eradication
    NIH/NIMH R21MH096619Jan 11, 2012 - Dec 31, 2014
    Role: Principal Investigator
    HIV Tropism, Persistence, Inflammation and Neurocognition in Therapy Initiation
    NIH P01MH094177Aug 22, 2011 - May 31, 2016
    Role: Co-Investigator
    Central Nervous System HIV Translational Research Training Program
    NIH/NIMH T32MH090847Jun 1, 2010 - May 31, 2015
    Role: Principal Investigator
    HIV Proteomic Center for Host-Viral Response Characterization
    NIH P01DA026134Sep 30, 2008 - May 31, 2012
    Role: Co-Investigator
    The Neuropathobiology of Primary HIV-1 Infection
    NIH/NIMH R01MH081772Sep 1, 2008 - Jan 31, 2014
    Role: Co-Principal Investigator
    Pilot Study of Treatment Augmentation on CNS Immunoactivation in Treated HIV-1 In
    NIH/NIMH R21MH083520Apr 1, 2008 - Jul 31, 2011
    Role: Principal Investigator
    CSF Molecular Marker Study Consortium
    NIH/NINDS R01NS043103Feb 15, 2002 - Jan 31, 2008
    Role: Principal Investigator
    CSF &Lymphocyte Dynamics in HIV Infection
    NIH/NIMH R01MH062701Sep 30, 2000 - Nov 30, 2011
    Role: Principal Investigator
    Treatment&Pathogenesis of Cerebrospinal Fluid HIV Infect
    NIH/NINDS R01NS037660May 15, 1998 - Apr 30, 2006
    Role: Principal Investigator
    HEREDITARY ATAXIA--MOLECULAR GENETICS &PATHOPHYSIOLOGY
    NIH P01NS033718Jan 1, 1995 - Dec 31, 2000
    Role: Co-Investigator
    PREVENTING DEPRESSION IN COUPLES FACING JOB LOSS
    NIH/NIMH R10MH052913Sep 1, 1994 - Aug 31, 2000
    Role: Principal Investigator
    NEUROLOGIC AIDS RESEARCH CONSORTIUM
    NIH R01NS032228Dec 1, 1993 - Jul 31, 2003
    Role: Co-Investigator
    HIV, AIDS AND THE BRAIN
    NIH/NINDS R13NS031341Nov 15, 1992 - Nov 14, 1993
    Role: Principal Investigator
    MICHIGAN PREVENTION RESEARCH CENTER
    NIH/NIMH P30MH038330Dec 1, 1989 - Aug 31, 2004
    Role: Principal Investigator
    AIDS DEMENTIA COMPLEX
    NIH/NINDS P01NS025701Feb 1, 1988 - Jan 31, 1999
    Role: Co-Principal Investigator
    AIDS DEMENTIA
    NIH/NINDS R01NS021703Dec 1, 1985 - Nov 30, 1988
    Role: Principal Investigator
    MICHIGAN PREVENTION RESEARCH CENTER
    NIH/NIMH P50MH038330Sep 15, 1983 - Nov 30, 1994
    Role: Principal Investigator
    Drug Abuse Treatment System Survey
    NIH/NIDA R01DA003272Mar 1, 1983 - Apr 30, 2008
    Role: Co-Principal Investigator
    REGIONAL BRAIN METABOLISM IN VIRAL ENCEPHALITIS
    NIH/NINDS R01NS019048Jan 1, 1983 - Jun 30, 1989
    Role: Principal Investigator
    General Clinical Research Center
    NIH/NCRR M01RR000083Oct 1, 1974 - Nov 30, 2007
    Role: Co-Investigator

    Collapse ORNG Applications 
    Collapse Global Health

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Chow FC, Price R, Hsue PY, Kim AS. Greater Risk of Stroke of Undetermined Etiology in a Contemporary HIV-Infected Cohort Compared with Uninfected Individuals. J Stroke Cerebrovasc Dis. 2017 Mar 02. PMID: 28262563.
      View in: PubMed
    2. Chow FC, Li Y, Hu Y, Chan J, Wang H, Xu W, Price RW, Sorond FA, Li T. Relationship between HIV infection, antiretroviral therapy, inflammatory markers and cerebrovascular endothelial function among adults in urban China. J Acquir Immune Defic Syndr. 2016 Nov 21. PMID: 27875362.
      View in: PubMed
    3. Anesten B, Yilmaz A, Hagberg L, Zetterberg H, Nilsson S, Brew BJ, Fuchs D, Price RW, Gisslén M. Blood-brain barrier integrity, intrathecal immunoactivation, and neuronal injury in HIV. Neurol Neuroimmunol Neuroinflamm. 2016 Dec; 3(6):e300. PMID: 27868081.
      View in: PubMed
    4. Joseph J, Cinque P, Colosi D, Dravid A, Ene L, Fox H, Gabuzda D, Gisslen M, Beth Joseph S, Letendre S, Mukerji SS, Nath A, Perez-Valero I, Persaud D, Price RW, Rao VR, Sacktor N, Swanstrom R, Winston A, Wojna V, Wright E, Spudich S. Highlights of the Global HIV-1 CSF Escape Consortium Meeting, 9 June 2016, Bethesda, MD, USA. J Virus Erad. 2016 Oct 5; 2(4):243-250. PMID: 27781109.
      View in: PubMed
    5. Krut JJ, Price RW, Zetterberg H, Fuchs D, Hagberg L, Yilmaz A, Cinque P, Nilsson S, Gisslén M. No support for premature central nervous system aging in HIV-1 when measured by cerebrospinal fluid phosphorylated tau (p-tau). Virulence. 2016 Jul 19; 1-6. PMID: 27435879.
      View in: PubMed
    6. Wright PW, Pyakurel A, Vaida FF, Price RW, Lee E, Peterson J, Fuchs D, Zetterberg H, Robertson KR, Walter R, Meyerhoff DJ, Spudich SS, Ances BM. Putamen volume and its clinical and neurological correlates in primary HIV infection. AIDS. 2016 Jul 17; 30(11):1789-94. PMID: 27045376.
      View in: PubMed
    7. Edén A, Marcotte TD, Heaton RK, Nilsson S, Zetterberg H, Fuchs D, Franklin D, Price RW, Grant I, Letendre SL, Gisslén M. Increased Intrathecal Immune Activation in Virally Suppressed HIV-1 Infected Patients with Neurocognitive Impairment. PLoS One. 2016; 11(6):e0157160. PMID: 27295036.
      View in: PubMed
    8. Ganesh A, Lemongello D, Lee E, Peterson J, McLaughlin BE, Ferre AL, Gillespie GM, Fuchs D, Deeks SG, Hunt PW, Price R, Spudich SS, Shacklett BL, et al. Immune Activation and HIV-Specific CD8(+) T Cells in Cerebrospinal Fluid of HIV Controllers and Noncontrollers. AIDS Res Hum Retroviruses. 2016 May 2. PMID: 27019338.
      View in: PubMed
    9. Chow FC, Boscardin WJ, Mills C, Ko N, Carroll C, Price R, Deeks S, Sorond FA, Hsue PY. Cerebral vasoreactivity is impaired in treated, virally suppressed HIV-infected individuals. AIDS. 2016 Jan 2; 30(1):45-55. PMID: 26372478.
      View in: PubMed
    10. Gisslén M, Price RW, Andreasson U, Norgren N, Nilsson S, Hagberg L, Fuchs D, Spudich S, Blennow K, Zetterberg H. Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study. EBioMedicine. 2016 Jan; 3:135-40. PMID: 26870824.
      View in: PubMed
    11. Arrildt KT, LaBranche CC, Joseph SB, Dukhovlinova EN, Graham WD, Ping LH, Schnell G, Sturdevant CB, Kincer LP, Mallewa M, Heyderman RS, Van Rie A, Cohen MS, Spudich S, Price RW, Montefiori DC, Swanstrom R. Phenotypic Correlates of HIV-1 Macrophage Tropism. J Virol. 2015 Nov 15; 89(22):11294-311. PMID: 26339058.
      View in: PubMed
    12. Ferretti F, Gisslen M, Cinque P, Price RW. Cerebrospinal Fluid HIV Escape from Antiretroviral Therapy. Curr HIV/AIDS Rep. 2015 Jun; 12(2):280-8. PMID: 25860317.
      View in: PubMed
    13. Wright EJ, Grund B, Cysique LA, Robertson KR, Brew BJ, Collins G, Shlay JC, Winston A, Read TR, Price RW. Factors associated with neurocognitive test performance at baseline: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. HIV Med. 2015 Apr; 16 Suppl 1:97-108. PMID: 25711328.
      View in: PubMed
    14. Sturdevant CB, Joseph SB, Schnell G, Price RW, Swanstrom R, Spudich S. Compartmentalized replication of R5 T cell-tropic HIV-1 in the central nervous system early in the course of infection. PLoS Pathog. 2015 Mar; 11(3):e1004720. PMID: 25811757; PMCID: PMC4374811.
    15. Wright PW, Vaida FF, Fernández RJ, Rutlin J, Price RW, Lee E, Peterson J, Fuchs D, Shimony JS, Robertson KR, Walter R, Meyerhoff DJ, Spudich S, Ances BM. Cerebral white matter integrity during primary HIV infection. AIDS. 2015 Feb 20; 29(4):433-42. PMID: 25513818.
      View in: PubMed
    16. Gega A, Kozal MJ, Chiarella J, Lee E, Peterson J, Hecht FM, Liegler T, St John EP, Simen BB, Price RW, Spudich SS. Deep sequencing of HIV-1 variants from paired plasma and cerebrospinal fluid during primary HIV infection. J Virus Erad. 2015; 1(4):264-268. PMID: 26855971.
      View in: PubMed
    17. Peterson J, Gisslen M, Zetterberg H, Fuchs D, Shacklett BL, Hagberg L, Yiannoutsos CT, Spudich SS, Price RW. Cerebrospinal fluid (CSF) neuronal biomarkers across the spectrum of HIV infection: hierarchy of injury and detection. PLoS One. 2014; 9(12):e116081. PMID: 25541953; PMCID: PMC4277428.
    18. Suh J, Sinclair E, Peterson J, Lee E, Kyriakides TC, Li FY, Hagberg L, Fuchs D, Price RW, Gisslen M, Spudich S. Progressive increase in central nervous system immune activation in untreated primary HIV-1 infection. J Neuroinflammation. 2014; 11:199. PMID: 25465205; PMCID: PMC4263211.
    19. Chow FC, Bacchetti P, Kim AS, Price RW, Hsue PY. Effect of CD4+ cell count and viral suppression on risk of ischemic stroke in HIV infection. AIDS. 2014 Nov 13; 28(17):2573-7. PMID: 25160935.
      View in: PubMed
    20. Young AC, Yiannoutsos CT, Hegde M, Lee E, Peterson J, Walter R, Price RW, Meyerhoff DJ, Spudich S. Cerebral metabolite changes prior to and after antiretroviral therapy in primary HIV infection. Neurology. 2014 Oct 28; 83(18):1592-600. PMID: 25261502; PMCID: PMC4223087.
    21. Dahl V, Peterson J, Fuchs D, Gisslen M, Palmer S, Price RW. Low levels of HIV-1 RNA detected in the cerebrospinal fluid after up to 10 years of suppressive therapy are associated with local immune activation. AIDS. 2014 Sep 24; 28(15):2251-8. PMID: 25022595; PMCID: PMC4492794.
    22. Wang SX, Ho EL, Grill M, Lee E, Peterson J, Robertson K, Fuchs D, Sinclair E, Price RW, Spudich S. Peripheral neuropathy in primary HIV infection associates with systemic and central nervous system immune activation. J Acquir Immune Defic Syndr. 2014 Jul 1; 66(3):303-10. PMID: 24732871; PMCID: PMC4147038.
    23. Gold JA, Grill M, Peterson J, Pilcher C, Lee E, Hecht FM, Fuchs D, Yiannoutsos CT, Price RW, Robertson K, Spudich S. Longitudinal characterization of depression and mood states beginning in primary HIV infection. AIDS Behav. 2014 Jun; 18(6):1124-32. PMID: 24385231.
      View in: PubMed
    24. Price RW, Spudich SS, Peterson J, Joseph S, Fuchs D, Zetterberg H, Gisslén M, Swanstrom R. Evolving character of chronic central nervous system HIV infection. Semin Neurol. 2014 Feb; 34(1):7-13. PMID: 24715483; PMCID: PMC4120280.
    25. Jessen Krut J, Mellberg T, Price RW, Hagberg L, Fuchs D, Rosengren L, Nilsson S, Zetterberg H, Gisslén M. Biomarker evidence of axonal injury in neuroasymptomatic HIV-1 patients. PLoS One. 2014; 9(2):e88591. PMID: 24523921; PMCID: PMC3921217.
    26. Grill MF, Price RW. Central nervous system HIV-1 infection. Handb Clin Neurol. 2014; 123:487-505. PMID: 25015501.
      View in: PubMed
    27. Dahl V, Gisslen M, Hagberg L, Peterson J, Shao W, Spudich S, Price RW, Palmer S. An example of genetically distinct HIV type 1 variants in cerebrospinal fluid and plasma during suppressive therapy. J Infect Dis. 2014 May 15; 209(10):1618-22. PMID: 24338353; PMCID: PMC3997583.
    28. Meyer AC, Boscardin WJ, Kwasa JK, Price RW. Is it time to rethink how neuropsychological tests are used to diagnose mild forms of HIV-associated neurocognitive disorders? Impact of false-positive rates on prevalence and power. Neuroepidemiology. 2013; 41(3-4):208-16. PMID: 24157541; PMCID: PMC4019399.
    29. Cettomai D, Kwasa JK, Birbeck GL, Price RW, Cohen CR, Bukusi EA, Kendi C, Meyer AC. Screening for HIV-associated peripheral neuropathy in resource-limited settings. Muscle Nerve. 2013 Oct; 48(4):516-24. PMID: 24037693; PMCID: PMC4019398.
    30. Grund B, Wright EJ, Brew BJ, Price RW, Roediger MP, Bain MP, Hoy JF, Shlay JC, Vjecha MJ, Robertson KR. Improved neurocognitive test performance in both arms of the SMART study: impact of practice effect. J Neurovirol. 2013 Aug; 19(4):383-92. PMID: 23943468; PMCID: PMC3963803.
    31. Price RW, Peterson J, Fuchs D, Angel TE, Zetterberg H, Hagberg L, Spudich S, Smith RD, Jacobs JM, Brown JN, Gisslen M. Approach to cerebrospinal fluid (CSF) biomarker discovery and evaluation in HIV infection. J Neuroimmune Pharmacol. 2013 Dec; 8(5):1147-58. PMID: 23943280; PMCID: PMC3889225.
    32. Ho EL, Ronquillo R, Altmeppen H, Spudich SS, Price RW, Sinclair E. Cellular Composition of Cerebrospinal Fluid in HIV-1 Infected and Uninfected Subjects. PLoS One. 2013; 8(6):e66188. PMID: 23822975.
      View in: PubMed
    33. Yilmaz A, Yiannoutsos CT, Fuchs D, Price RW, Crozier K, Hagberg L, Spudich S, Gisslén M. Cerebrospinal fluid neopterin decay characteristics after initiation of antiretroviral therapy. J Neuroinflammation. 2013; 10:62. PMID: 23664008; PMCID: PMC3657550.
    34. Yukl SA, Boritz E, Busch M, Bentsen C, Chun TW, Douek D, Eisele E, Haase A, Ho YC, Hütter G, Justement JS, Keating S, Lee TH, Li P, Murray D, Palmer S, Pilcher C, Pillai S, Price RW, Rothenberger M, Schacker T, Siliciano J, Siliciano R, Sinclair E, Strain M, Wong J, Richman D, Deeks SG. Challenges in detecting HIV persistence during potentially curative interventions: a study of the Berlin patient. PLoS Pathog. 2013; 9(5):e1003347. PMID: 23671416; PMCID: PMC3649997.
    35. Dahl V, Peterson J, Spudich S, Lee E, Shacklett BL, Price RW, Palmer S. Single-copy assay quantification of HIV-1 RNA in paired cerebrospinal fluid and plasma samples from elite controllers. AIDS. 2013 Apr 24; 27(7):1145-9. PMID: 23211774; PMCID: PMC4004626.
    36. Peluso MJ, Meyerhoff DJ, Price RW, Peterson J, Lee E, Young AC, Walter R, Fuchs D, Brew BJ, Cinque P, Robertson K, Hagberg L, Zetterberg H, Gisslén M, Spudich S. Cerebrospinal fluid and neuroimaging biomarker abnormalities suggest early neurological injury in a subset of individuals during primary HIV infection. J Infect Dis. 2013 Jun 1; 207(11):1703-12. PMID: 23460748; PMCID: PMC3636785.
    37. Krut JJ, Zetterberg H, Blennow K, Cinque P, Hagberg L, Price RW, Studahl M, Gisslén M. Cerebrospinal fluid Alzheimer's biomarker profiles in CNS infections. J Neurol. 2013 Feb; 260(2):620-6. PMID: 23052602.
      View in: PubMed
    38. Price RW, Swanstrom R. Targeting chronic central nervous system HIV infection. Antivir Ther. 2012; 17(7):1227-31. PMID: 23018178.
      View in: PubMed
    39. Peluso MJ, Ferretti F, Peterson J, Lee E, Fuchs D, Boschini A, Gisslén M, Angoff N, Price RW, Cinque P, Spudich S. Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load. AIDS. 2012 Sep 10; 26(14):1765-74. PMID: 22614889; PMCID: PMC3881435.
    40. Fanara P, Wong PY, Husted KH, Liu S, Liu VM, Kohlstaedt LA, Riiff T, Protasio JC, Boban D, Killion S, Killian M, Epling L, Sinclair E, Peterson J, Price RW, Cabin DE, Nussbaum RL, Brühmann J, Brandt R, Christine CW, Aminoff MJ, Hellerstein MK. Cerebrospinal fluid-based kinetic biomarkers of axonal transport in monitoring neurodegeneration. J Clin Invest. 2012 Sep; 122(9):3159-69. PMID: 22922254; PMCID: PMC3428100.
    41. Angel TE, Jacobs JM, Spudich SS, Gritsenko MA, Fuchs D, Liegler T, Zetterberg H, Camp DG, Price RW, Smith RD. The cerebrospinal fluid proteome in HIV infection: change associated with disease severity. Clin Proteomics. 2012; 9(1):3. PMID: 22433316; PMCID: PMC3353874.
    42. Kwasa J, Cettomai D, Lwanya E, Osiemo D, Oyaro P, Birbeck GL, Price RW, Bukusi EA, Cohen CR, Meyer AC. Lessons learned developing a diagnostic tool for HIV-associated dementia feasible to implement in resource-limited settings: pilot testing in Kenya. PLoS One. 2012; 7(3):e32898. PMID: 22412945; PMCID: PMC3296754.
    43. Gisslén M, Price RW, Nilsson S. The definition of HIV-associated neurocognitive disorders: are we overestimating the real prevalence? BMC Infect Dis. 2011; 11:356. PMID: 22204557; PMCID: PMC3260107.
    44. Yilmaz A, Price RW, Gisslén M. Antiretroviral drug treatment of CNS HIV-1 infection. J Antimicrob Chemother. 2012 Feb; 67(2):299-311. PMID: 22160207.
      View in: PubMed
    45. Dahl V, Lee E, Peterson J, Spudich SS, Leppla I, Sinclair E, Fuchs D, Palmer S, Price RW. Raltegravir treatment intensification does not alter cerebrospinal fluid HIV-1 infection or immunoactivation in subjects on suppressive therapy. J Infect Dis. 2011 Dec 15; 204(12):1936-45. PMID: 22021620; PMCID: PMC3209817.
    46. Schnell G, Joseph S, Spudich S, Price RW, Swanstrom R. HIV-1 replication in the central nervous system occurs in two distinct cell types. PLoS Pathog. 2011 Oct; 7(10):e1002286. PMID: 22007152; PMCID: PMC3188520.
    47. Spudich S, Gisslen M, Hagberg L, Lee E, Liegler T, Brew B, Fuchs D, Tambussi G, Cinque P, Hecht FM, Price RW. Central nervous system immune activation characterizes primary human immunodeficiency virus 1 infection even in participants with minimal cerebrospinal fluid viral burden. J Infect Dis. 2011 Sep 1; 204(5):753-60. PMID: 21844301; PMCID: PMC3156103.
    48. Robertson K, Kumwenda J, Supparatpinyo K, Jiang JH, Evans S, Campbell TB, Price RW, Murphy R, Hall C, Marra CM, Marcus C, Berzins B, Masih R, Santos B, Silva MT, Kumarasamy N, Walawander A, Nair A, Tripathy S, Kanyama C, Hosseinipour M, Montano S, La Rosa A, Amod F, Sanne I, Firnhaber C, Hakim J, Brouwers P. A multinational study of neurological performance in antiretroviral therapy-naïve HIV-1-infected persons in diverse resource-constrained settings. J Neurovirol. 2011 Oct; 17(5):438-47. PMID: 21786076; PMCID: PMC3362044.
    49. Cettomai D, Kwasa J, Birbeck GL, Price RW, Bukusi EA, Meyer AC. Training needs and evaluation of a neuro-HIV training module for non-physician healthcare workers in western Kenya. J Neurol Sci. 2011 Aug 15; 307(1-2):92-6. PMID: 21652049; PMCID: PMC3166624.
    50. Ho EL, Spudich SS, Lee E, Fuchs D, Sinclair E, Price RW. Minocycline fails to modulate cerebrospinal fluid HIV infection or immune activation in chronic untreated HIV-1 infection: results of a pilot study. AIDS Res Ther. 2011; 8:17. PMID: 21569420; PMCID: PMC3117676.
    51. Price RW. Impact of antiretroviral therapy on HIV-related brain injury. Clin Infect Dis. 2011 Jan 15; 52(2):244-7. PMID: 21288851; PMCID: PMC3060892.
    52. Cettomai D, Kwasa J, Kendi C, Birbeck GL, Price RW, Bukusi EA, Cohen CR, Meyer AC. Utility of quantitative sensory testing and screening tools in identifying HIV-associated peripheral neuropathy in Western Kenya: pilot testing. PLoS One. 2010; 5(12):e14256. PMID: 21170387; PMCID: PMC2999535.
    53. Edén A, Fuchs D, Hagberg L, Nilsson S, Spudich S, Svennerholm B, Price RW, Gisslén M. HIV-1 viral escape in cerebrospinal fluid of subjects on suppressive antiretroviral treatment. J Infect Dis. 2010 Dec 15; 202(12):1819-25. PMID: 21050119; PMCID: PMC3052942.
    54. Wright EJ, Grund B, Robertson K, Brew BJ, Roediger M, Bain MP, Drummond F, Vjecha MJ, Hoy J, Miller C, Penalva de Oliveira AC, Pumpradit W, Shlay JC, El-Sadr W, Price RW. Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons. Neurology. 2010 Sep 7; 75(10):864-73. PMID: 20702792; PMCID: PMC2938971.
    55. Hagberg L, Cinque P, Gisslen M, Brew BJ, Spudich S, Bestetti A, Price RW, Fuchs D. Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection. AIDS Res Ther. 2010; 7:15. PMID: 20525234; PMCID: PMC2890504.
    56. Probasco JC, Deeks SG, Lee E, Hoh R, Hunt PW, Liegler T, Price RW, Spudich SS. Cerebrospinal fluid in HIV-1 systemic viral controllers: absence of HIV-1 RNA and intrathecal inflammation. AIDS. 2010 Apr 24; 24(7):1001-5. PMID: 20299968.
      View in: PubMed
    57. Gisslén M, Krut J, Andreasson U, Blennow K, Cinque P, Brew BJ, Spudich S, Hagberg L, Rosengren L, Price RW, Zetterberg H. Amyloid and tau cerebrospinal fluid biomarkers in HIV infection. BMC Neurol. 2009; 9:63. PMID: 20028512; PMCID: PMC2807422.
    58. Schnell G, Price RW, Swanstrom R, Spudich S. Compartmentalization and clonal amplification of HIV-1 variants in the cerebrospinal fluid during primary infection. J Virol. 2010 Mar; 84(5):2395-407. PMID: 20015984; PMCID: PMC2820937.
    59. Franciotta D, Bestetti A, Sala S, Perucca P, Jarius S, Price RW, Di Stefano AL, Cinque P. Broad screening for human herpesviridae DNA in multiple sclerosis cerebrospinal fluid and serum. Acta Neurol Belg. 2009 Dec; 109(4):277-82. PMID: 20120207.
      View in: PubMed
    60. Cinque P, Koralnik IJ, Gerevini S, Miro JM, Price RW. Progressive multifocal leukoencephalopathy in HIV-1 infection. Lancet Infect Dis. 2009 Oct; 9(10):625-36. PMID: 19778765; PMCID: PMC2919371.
    61. Yilmaz A, Gisslén M, Spudich S, Lee E, Jayewardene A, Aweeka F, Price RW. Raltegravir cerebrospinal fluid concentrations in HIV-1 infection. PLoS One. 2009; 4(9):e6877. PMID: 19721718; PMCID: PMC2731205.
    62. Harrington PR, Schnell G, Letendre SL, Ritola K, Robertson K, Hall C, Burch CL, Jabara CB, Moore DT, Ellis RJ, Price RW, Swanstrom R. Cross-sectional characterization of HIV-1 env compartmentalization in cerebrospinal fluid over the full disease course. AIDS. 2009 May 15; 23(8):907-15. PMID: 19414991; PMCID: PMC3089803.
    63. Schnell G, Spudich S, Harrington P, Price RW, Swanstrom R. Compartmentalized human immunodeficiency virus type 1 originates from long-lived cells in some subjects with HIV-1-associated dementia. PLoS Pathog. 2009 Apr; 5(4):e1000395. PMID: 19390619; PMCID: PMC2668697.
    64. Yilmaz A, Izadkhashti A, Price RW, Mallon PW, De Meulder M, Timmerman P, Gisslén M. Darunavir concentrations in cerebrospinal fluid and blood in HIV-1-infected individuals. AIDS Res Hum Retroviruses. 2009 Apr; 25(4):457-61. PMID: 19320601; PMCID: PMC2853865.
    65. Ince WL, Harrington PR, Schnell GL, Patel-Chhabra M, Burch CL, Menezes P, Price RW, Eron JJ, Swanstrom RI. Major coexisting human immunodeficiency virus type 1 env gene subpopulations in the peripheral blood are produced by cells with similar turnover rates and show little evidence of genetic compartmentalization. J Virol. 2009 May; 83(9):4068-80. PMID: 19211740; PMCID: PMC2668457.
    66. Buescher JL, Duan F, Sun J, Price RW, Ikezu T. OTK18 levels in plasma and cerebrospinal fluid correlate with viral load and CD8 T-cells in normal and AIDS patients. J Neuroimmune Pharmacol. 2008 Dec; 3(4):230-5. PMID: 18773297; PMCID: PMC2581637.
    67. Probasco JC, Spudich SS, Critchfield J, Lee E, Lollo N, Deeks SG, Price RW. Failure of atorvastatin to modulate CSF HIV-1 infection: results of a pilot study. Neurology. 2008 Aug 12; 71(7):521-4. PMID: 18695163; PMCID: PMC2676982.
    68. Price RW, Spudich S. Antiretroviral therapy and central nervous system HIV type 1 infection. J Infect Dis. 2008 May 15; 197 Suppl 3:S294-306. PMID: 18447615; PMCID: PMC2628635.
    69. Lifson AR, Belloso WH, Carey C, Davey RT, Duprez D, El-Sadr WM, Gatell JM, Gey DC, Hoy JF, Krum EA, Nelson R, Nixon DE, Paton N, Pedersen C, Perez G, Price RW, Prineas RJ, Rhame FS, Sampson J, Worley J. Determination of the underlying cause of death in three multicenter international HIV clinical trials. HIV Clin Trials. 2008 May-Jun; 9(3):177-85. PMID: 18547904; PMCID: PMC2441601.
    70. Sinclair E, Ronquillo R, Lollo N, Deeks SG, Hunt P, Yiannoutsos CT, Spudich S, Price RW. Antiretroviral treatment effect on immune activation reduces cerebrospinal fluid HIV-1 infection. J Acquir Immune Defic Syndr. 2008 Apr 15; 47(5):544-52. PMID: 18362693; PMCID: PMC3480328.
    71. Yilmaz A, Price RW, Spudich S, Fuchs D, Hagberg L, Gisslén M. Persistent intrathecal immune activation in HIV-1-infected individuals on antiretroviral therapy. J Acquir Immune Defic Syndr. 2008 Feb 1; 47(2):168-73. PMID: 17971711; PMCID: PMC2628632.
    72. Price RW, Parham R, Kroll JL, Wring SA, Baker B, Sailstad J, Hoh R, Liegler T, Spudich S, Kuritzkes DR, Deeks SG. Enfuvirtide cerebrospinal fluid (CSF) pharmacokinetics and potential use in defining CSF HIV-1 origin. Antivir Ther. 2008; 13(3):369-74. PMID: 18572749; PMCID: PMC2699482.
    73. Edén A, Price RW, Spudich S, Fuchs D, Hagberg L, Gisslén M. Immune activation of the central nervous system is still present after >4 years of effective highly active antiretroviral therapy. J Infect Dis. 2007 Dec 15; 196(12):1779-83. PMID: 18190258.
      View in: PubMed
    74. Price RW, Epstein LG, Becker JT, Cinque P, Gisslen M, Pulliam L, McArthur JC. Biomarkers of HIV-1 CNS infection and injury. Neurology. 2007 Oct 30; 69(18):1781-8. PMID: 17967994.
      View in: PubMed
    75. Mellgren A, Price RW, Hagberg L, Rosengren L, Brew BJ, Gisslén M. Antiretroviral treatment reduces increased CSF neurofilament protein (NFL) in HIV-1 infection. Neurology. 2007 Oct 9; 69(15):1536-41. PMID: 17923616.
      View in: PubMed
    76. Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007 Oct 30; 69(18):1789-99. PMID: 17914061; PMCID: PMC4472366.
    77. Gisslen M, Hagberg L, Brew BJ, Cinque P, Price RW, Rosengren L. Elevated cerebrospinal fluid neurofilament light protein concentrations predict the development of AIDS dementia complex. J Infect Dis. 2007 Jun 15; 195(12):1774-8. PMID: 17492593.
      View in: PubMed
    78. Abdulle S, Mellgren A, Brew BJ, Cinque P, Hagberg L, Price RW, Rosengren L, Gisslén M. CSF neurofilament protein (NFL) -- a marker of active HIV-related neurodegeneration. J Neurol. 2007 Aug; 254(8):1026-32. PMID: 17420923.
      View in: PubMed
    79. Brew BJ, Halman M, Catalan J, Sacktor N, Price RW, Brown S, Atkinson H, Clifford DB, Simpson D, Torres G, Hall C, Power C, Marder K, Mc Arthur JC, Symonds W, Romero C. Factors in AIDS dementia complex trial design: results and lessons from the abacavir trial. PLoS Clin Trials. 2007; 2(3):e13. PMID: 17401456; PMCID: PMC1845158.
    80. Cinque P, Brew BJ, Gisslen M, Hagberg L, Price RW. Cerebrospinal fluid markers in central nervous system HIV infection and AIDS dementia complex. Handb Clin Neurol. 2007; 85:261-300. PMID: 18808988.
      View in: PubMed
    81. Spudich S, Lollo N, Liegler T, Deeks SG, Price RW. Treatment benefit on cerebrospinal fluid HIV-1 levels in the setting of systemic virological suppression and failure. J Infect Dis. 2006 Dec 15; 194(12):1686-96. PMID: 17109340.
      View in: PubMed
    82. Robertson KR, Parsons TD, Sidtis JJ, Hanlon Inman T, Robertson WT, Hall CD, Price RW. Timed Gait test: normative data for the assessment of the AIDS dementia complex. J Clin Exp Neuropsychol. 2006 Oct; 28(7):1053-64. PMID: 16840235.
      View in: PubMed
    83. Gisslen M, Hagberg L, Rosengren L, Brew BJ, Cinque P, Spudich S, Price RW. Defining and evaluating HIV-related neurodegenerative disease and its treatment targets: a combinatorial approach to use of cerebrospinal fluid molecular biomarkers. J Neuroimmune Pharmacol. 2007 Mar; 2(1):112-9. PMID: 18040834.
      View in: PubMed
    84. Hunt PW, Harrigan PR, Huang W, Bates M, Williamson DW, McCune JM, Price RW, Spudich SS, Lampiris H, Hoh R, Leigler T, Martin JN, Deeks SG. Prevalence of CXCR4 tropism among antiretroviral-treated HIV-1-infected patients with detectable viremia. J Infect Dis. 2006 Oct 1; 194(7):926-30. PMID: 16960780.
      View in: PubMed
    85. Spudich SS, Nilsson AC, Lollo ND, Liegler TJ, Petropoulos CJ, Deeks SG, Paxinos EE, Price RW. Cerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatment. BMC Infect Dis. 2005; 5:98. PMID: 16266436; PMCID: PMC1299327.
    86. Neuenburg JK, Furlan S, Bacchetti P, Price RW, Grant RM. Enrichment of activated monocytes in cerebrospinal fluid during antiretroviral therapy. AIDS. 2005 Sep 2; 19(13):1351-9. PMID: 16103765.
      View in: PubMed
    87. Gisslén M, Rosengren L, Hagberg L, Deeks SG, Price RW. Cerebrospinal fluid signs of neuronal damage after antiretroviral treatment interruption in HIV-1 infection. AIDS Res Ther. 2005 Aug 18; 2:6. PMID: 16109178; PMCID: PMC1198215.
    88. Cinque P, Bestetti A, Marenzi R, Sala S, Gisslen M, Hagberg L, Price RW. Cerebrospinal fluid interferon-gamma-inducible protein 10 (IP-10, CXCL10) in HIV-1 infection. J Neuroimmunol. 2005 Nov; 168(1-2):154-63. PMID: 16091292.
      View in: PubMed
    89. Cysique LA, Brew BJ, Halman M, Catalan J, Sacktor N, Price RW, Brown S, Atkinson JH, Clifford DB, Simpson D, Torres G, Hall C, Power C, Marder K, McArthur JC, Symonds W, Romero C. Undetectable cerebrospinal fluid HIV RNA and beta-2 microglobulin do not indicate inactive AIDS dementia complex in highly active antiretroviral therapy-treated patients. J Acquir Immune Defic Syndr. 2005 Aug 1; 39(4):426-9. PMID: 16010165.
      View in: PubMed
    90. Neuenburg JK, Cho TA, Nilsson A, Bredt BM, Hebert SJ, Grant RM, Price RW. T-cell activation and memory phenotypes in cerebrospinal fluid during HIV infection. J Acquir Immune Defic Syndr. 2005 May 1; 39(1):16-22. PMID: 15851909.
      View in: PubMed
    91. Price RW, Robertson K. Editorial comment: déjà vu--neurologic complications of HIV infection in the expanding epidemic. AIDS Read. 2005 Mar; 15(3):144. PMID: 15786578.
      View in: PubMed
    92. Spudich SS, Huang W, Nilsson AC, Petropoulos CJ, Liegler TJ, Whitcomb JM, Price RW. HIV-1 chemokine coreceptor utilization in paired cerebrospinal fluid and plasma samples: a survey of subjects with viremia. J Infect Dis. 2005 Mar 15; 191(6):890-8. PMID: 15717264.
      View in: PubMed
    93. Cinque P, Robertson K, Antinori A, Price RW. Neurological complications of HIV infection and AIDS: current and future perspectives. J Neurovirol. 2005; 11 Suppl 3:1-5. PMID: 16540446.
      View in: PubMed
    94. Mellgren A, Antinori A, Cinque P, Price RW, Eggers C, Hagberg L, Gisslén M. Cerebrospinal fluid HIV-1 infection usually responds well to antiretroviral treatment. Antivir Ther. 2005; 10(6):701-7. PMID: 16218168.
      View in: PubMed
    95. Sidenius N, Nebuloni M, Sala S, Zerbi P, Price RW, Gisslen M, Hagberg L, Vago L, Lazzarin A, Blasi F, Cinque P. Expression of the urokinase plasminogen activator and its receptor in HIV-1-associated central nervous system disease. J Neuroimmunol. 2004 Dec; 157(1-2):133-9. PMID: 15579290.
      View in: PubMed
    96. Neuenburg JK, Sinclair E, Nilsson A, Kreis C, Bacchetti P, Price RW, Grant RM. HIV-producing T cells in cerebrospinal fluid. J Acquir Immune Defic Syndr. 2004 Oct 1; 37(2):1237-44. PMID: 15385730.
      View in: PubMed
    97. Kao AW, Price RW. Chemokine receptors, neural progenitor cells, and the AIDS dementia complex. J Infect Dis. 2004 Jul 15; 190(2):211-5. PMID: 15216453.
      View in: PubMed
    98. Shacklett BL, Cox CA, Wilkens DT, Karl Karlsson R, Nilsson A, Nixon DF, Price RW. Increased adhesion molecule and chemokine receptor expression on CD8+ T cells trafficking to cerebrospinal fluid in HIV-1 infection. J Infect Dis. 2004 Jun 15; 189(12):2202-12. PMID: 15181567.
      View in: PubMed
    99. Cinque P, Nebuloni M, Santovito ML, Price RW, Gisslen M, Hagberg L, Bestetti A, Vago G, Lazzarin A, Blasi F, Sidenius N. The urokinase receptor is overexpressed in the AIDS dementia complex and other neurological manifestations. Ann Neurol. 2004 May; 55(5):687-94. PMID: 15122709.
      View in: PubMed
    100. Valle M, Price RW, Nilsson A, Heyes M, Verotta D. CSF quinolinic acid levels are determined by local HIV infection: cross-sectional analysis and modelling of dynamics following antiretroviral therapy. Brain. 2004 May; 127(Pt 5):1047-60. PMID: 15013955.
      View in: PubMed
    101. Price RW, Deeks SG. Antiretroviral drug treatment interruption in human immunodeficiency virus-infected adults: Clinical and pathogenetic implications for the central nervous system. J Neurovirol. 2004; 10 Suppl 1:44-51. PMID: 14982739.
      View in: PubMed
    102. Neuenburg JK, Brodt HR, Herndier BG, Bickel M, Bacchetti P, Price RW, Grant RM, Schlote W. HIV-related neuropathology, 1985 to 1999: rising prevalence of HIV encephalopathy in the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2002 Oct 1; 31(2):171-7. PMID: 12394795.
      View in: PubMed
    103. Aberg JA, Price RW, Heeren DM, Bredt B. A pilot study of the discontinuation of antifungal therapy for disseminated cryptococcal disease in patients with acquired immunodeficiency syndrome, following immunologic response to antiretroviral therapy. J Infect Dis. 2002 Apr 15; 185(8):1179-82. PMID: 11930330.
      View in: PubMed
    104. Price RW. Screening for the AIDS dementia complex. AIDS Read. 2002 Jan; 12(1):32-3. PMID: 11862659.
      View in: PubMed
    105. Price RW, Paxinos EE, Grant RM, Drews B, Nilsson A, Hoh R, Hellmann NS, Petropoulos CJ, Deeks SG. Cerebrospinal fluid response to structured treatment interruption after virological failure. AIDS. 2001 Jul 6; 15(10):1251-9. PMID: 11426069.
      View in: PubMed
    106. Lanier ER, Sturge G, McClernon D, Brown S, Halman M, Sacktor N, McArthur J, Atkinson JH, Clifford D, Price RW, Simpson D, Torres G, Catalan J, Marder K, Power C, Hall C, Romero C, Brew B. HIV-1 reverse transcriptase sequence in plasma and cerebrospinal fluid of patients with AIDS dementia complex treated with Abacavir. AIDS. 2001 Apr 13; 15(6):747-51. PMID: 11371689.
      View in: PubMed
    107. Price RW. The two faces of HIV infection of cerebrospinal fluid. Trends Microbiol. 2000 Sep; 8(9):387-91. PMID: 10989300.
      View in: PubMed
    108. Eberly LE, Ohman PA, Neaton JD, Price RW, Abrams DI. Kaposi's sarcoma and central nervous system disease: a real association or an artifact of the control group? Terry Beirn Community Programs for Clinical Research on AIDS. AIDS. 2000 May 26; 14(8):995-1000. PMID: 10853981.
      View in: PubMed
    109. Price RW, Yiannoutsos CT, Clifford DB, Zaborski L, Tselis A, Sidtis JJ, Cohen B, Hall CD, Erice A, Henry K. Neurological outcomes in late HIV infection: adverse impact of neurological impairment on survival and protective effect of antiviral therapy. AIDS Clinical Trial Group and Neurological AIDS Research Consortium study team. AIDS. 1999 Sep 10; 13(13):1677-85. PMID: 10509569.
      View in: PubMed
    110. Staprans S, Marlowe N, Glidden D, Novakovic-Agopian T, Grant RM, Heyes M, Aweeka F, Deeks S, Price RW. Time course of cerebrospinal fluid responses to antiretroviral therapy: evidence for variable compartmentalization of infection. AIDS. 1999 Jun 18; 13(9):1051-61. PMID: 10397535.
      View in: PubMed
    111. Aweeka F, Jayewardene A, Staprans S, Bellibas SE, Kearney B, Lizak P, Novakovic-Agopian T, Price RW. Failure to detect nelfinavir in the cerebrospinal fluid of HIV-1--infected patients with and without AIDS dementia complex. J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Jan 1; 20(1):39-43. PMID: 9928728.
      View in: PubMed
    112. Green LA, Rhame FS, Price RW, Perlman DC, Capps LG, Sampson JH, Deyton LR, Schnittman SM, Fisher EJ, Bartsch GE, Krum EA, Neaton JD. Experience with a cross-study endpoint review committee for AIDS clinical trials. Terry Beirn Community Programs for Clinical Research on AIDS. AIDS. 1998 Oct 22; 12(15):1983-90. PMID: 9814866.
      View in: PubMed
    113. Price RW. Neuropathy complicating diffuse infiltrative lymphocytosis. Lancet. 1998 Aug 22; 352(9128):592-4. PMID: 9746016.
      View in: PubMed
    114. Price RW, Staprans S. Measuring the "viral load" in cerebrospinal fluid in human immunodeficiency virus infection: window into brain infection? Ann Neurol. 1997 Nov; 42(5):675-8. PMID: 9392565.
      View in: PubMed
    115. Sidtis JJ, Dafni U, Slasor P, Hall C, Price RW, Kieburtz K, Tucker T, Clifford DB. Stable neurological function in subjects treated with 2'3'-dideoxyinosine. J Neurovirol. 1997 Jun; 3(3):233-40. PMID: 9200072.
      View in: PubMed
    116. Price RW. Neurological complications of HIV infection. Lancet. 1996 Aug 17; 348(9025):445-52. PMID: 8709786.
      View in: PubMed
    117. Rottenberg DA, Sidtis JJ, Strother SC, Schaper KA, Anderson JR, Nelson MJ, Price RW. Abnormal cerebral glucose metabolism in HIV-1 seropositive subjects with and without dementia. J Nucl Med. 1996 Jul; 37(7):1133-41. PMID: 8965184.
      View in: PubMed
    118. Brew BJ, Wesselingh SL, Gonzales M, Heyes MP, Price RW. Managing HIV. Part 3: Mechanisms of diseases. 3.7 How HIV leads to neurological disease. Med J Aust. 1996 Feb 19; 164(4):233-4. PMID: 8604196.
      View in: PubMed
    119. Price RW. The cellular basis of central nervous system HIV-1 infection and the AIDS dementia complex: introduction. J NeuroAIDS. 1996; 1(1):1-29. PMID: 16873153.
      View in: PubMed
    120. Price RW. AIDS dementia complex: a complex, slow virus "model" of acquired genetic neurodegenerative disease. Cold Spring Harb Symp Quant Biol. 1996; 61:759-70. PMID: 9246501.
      View in: PubMed
    121. Brew BJ, Rosenblum M, Cronin K, Price RW. AIDS dementia complex and HIV-1 brain infection: clinical-virological correlations. Ann Neurol. 1995 Oct; 38(4):563-70. PMID: 7574452.
      View in: PubMed
    122. Price RW. Management of AIDS dementia complex and HIV-1 infection of the nervous system. AIDS. 1995; 9 Suppl A:S221-36. PMID: 8819589.
      View in: PubMed
    123. Price R. AIDS dementia complex and HIV-1 brain infection: a pathogenetic framework for treatment and evaluation. Curr Top Microbiol Immunol. 1995; 202:33-54. PMID: 7587369.
      View in: PubMed
    124. Brew BJ, Paul MO, Nakajima G, Khan A, Gallardo H, Price RW. Cerebrospinal fluid HIV-1 p24 antigen and culture: sensitivity and specificity for AIDS-dementia complex. J Neurol Neurosurg Psychiatry. 1994 Jul; 57(7):784-9. PMID: 8021661; PMCID: PMC1073015.
    125. Price RW. Understanding the AIDS dementia complex (ADC). The challenge of HIV and its effects on the central nervous system. Res Publ Assoc Res Nerv Ment Dis. 1994; 72:1-45. PMID: 8115708.
      View in: PubMed
    126. Sidtis JJ, Gatsonis C, Price RW, Singer EJ, Collier AC, Richman DD, Hirsch MS, Schaerf FW, Fischl MA, Kieburtz K. Zidovudine treatment of the AIDS dementia complex: results of a placebo-controlled trial. AIDS Clinical Trials Group. Ann Neurol. 1993 Apr; 33(4):343-9. PMID: 8489204.
      View in: PubMed
    127. Li Y, Hui H, Burgess CJ, Price R, Sharp PM, Hahn BH, Shaw GM. Complete nucleotide sequence, genome organization, and biological properties of human immunodeficiency virus type 1 in vivo: evidence for limited defectiveness and complementation. J Virol. 1992 Nov; 66(11):6587-600. PMID: 1404605; PMCID: PMC240154.
    128. Shaskan EG, Brew BJ, Rosenblum M, Thompson RM, Price R. Increased neopterin levels in brains of patients with human immunodeficiency virus type 1 infection. J Neurochem. 1992 Oct; 59(4):1541-6. PMID: 1328524.
      View in: PubMed
    129. Heyes MP, Brew BJ, Saito K, Quearry BJ, Price R, Lee K, Bhalla RB, Der M, Markey SP. Inter-relationships between quinolinic acid, neuroactive kynurenines, neopterin and beta 2-microglobulin in cerebrospinal fluid and serum of HIV-1-infected patients. J Neuroimmunol. 1992 Sep; 40(1):71-80. PMID: 1387655.
      View in: PubMed
    130. Shaskan EG, Thompson RM, Price R. Undetectable tumor necrosis factor-alpha in spinal fluid from HIV-1-infected patients. Ann Neurol. 1992 Jun; 31(6):687-9. PMID: 1514782.
      View in: PubMed
    131. Brew BJ, Bhalla RB, Paul M, Sidtis JJ, Keilp JJ, Sadler AE, Gallardo H, McArthur JC, Schwartz MK, Price R. Cerebrospinal fluid beta 2-microglobulin in patients with AIDS dementia complex: an expanded series including response to zidovudine treatment. AIDS. 1992 May; 6(5):461-5. PMID: 1616651.
      View in: PubMed
    132. Rosenblum MK, Brew BJ, Hahn B, Shaw G, Haase A, Maroushek S, Price R. Human T-lymphotropic virus type I-associated myelopathy in patients with the acquired immunodeficiency syndrome. Hum Pathol. 1992 May; 23(5):513-9. PMID: 1568747.
      View in: PubMed
    133. Westervelt P, Trowbridge DB, Epstein LG, Blumberg BM, Li Y, Hahn BH, Shaw GM, Price RW, Ratner L. Macrophage tropism determinants of human immunodeficiency virus type 1 in vivo. J Virol. 1992 Apr; 66(4):2577-82. PMID: 1548783; PMCID: PMC289061.
    134. Spencer DC, Price RW. Human immunodeficiency virus and the central nervous system. Annu Rev Microbiol. 1992; 46:655-93. PMID: 1444270.
      View in: PubMed
    135. Sweeney JA, Brew BJ, Keilp JG, Sidtis JJ, Price RW. Pursuit eye movement dysfunction in HIV-1 seropositive individuals. J Psychiatry Neurosci. 1991 Dec; 16(5):247-52. PMID: 1797099; PMCID: PMC1188361.
    136. Li Y, Kappes JC, Conway JA, Price R, Shaw GM, Hahn BH. Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: identification of replication-competent and -defective viral genomes. J Virol. 1991 Aug; 65(8):3973-85. PMID: 1830110; PMCID: PMC248827.
    137. Devinsky O, Cho ES, Petito CK, Price R. Herpes zoster myelitis. Brain. 1991 Jun; 114 ( Pt 3):1181-96. PMID: 1648419.
      View in: PubMed
    138. Price RW, Sidtis JJ, Brew BJ. AIDS dementia complex and HIV-1 infection: a view from the clinic. Brain Pathol. 1991 Apr; 1(3):155-62. PMID: 1669704.
      View in: PubMed
    139. Kaplan JE, Litchfield B, Rouault C, Lairmore MD, Luo CC, Williams L, Brew BJ, Price RW, Janssen R, Stoneburner R. HTLV-I-associated myelopathy associated with blood transfusion in the United States: epidemiologic and molecular evidence linking donor and recipient. Neurology. 1991 Feb; 41(2 ( Pt 1)):192-7. PMID: 1992361.
      View in: PubMed
    140. Heyes MP, Brew BJ, Martin A, Price RW, Salazar AM, Sidtis JJ, Yergey JA, Mouradian MM, Sadler AE, Keilp J. Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status. Ann Neurol. 1991 Feb; 29(2):202-9. PMID: 1826418.
      View in: PubMed
    141. Heyes MP, Brew B, Martin A, Markey SP, Price R, Bhalla RB, Salazar A. Cerebrospinal fluid quinolinic acid concentrations are increased in acquired immune deficiency syndrome. Adv Exp Med Biol. 1991; 294:687-90. PMID: 1837699.
      View in: PubMed
    142. Brew BJ, Bhalla RB, Paul M, Gallardo H, McArthur JC, Schwartz MK, Price R. Cerebrospinal fluid neopterin in human immunodeficiency virus type 1 infection. Ann Neurol. 1990 Oct; 28(4):556-60. PMID: 2252366.
      View in: PubMed
    143. Sidtis JJ, Price R. Early HIV-1 infection and the AIDS dementia complex. Neurology. 1990 Feb; 40(2):323-6. PMID: 2300258.
      View in: PubMed
    144. Price RW, Brew BJ, Rosenblum M. The AIDS dementia complex and HIV-1 brain infection: a pathogenetic model of virus-immune interaction. Res Publ Assoc Res Nerv Ment Dis. 1990; 68:269-90. PMID: 2183316.
      View in: PubMed
    145. Price R, Sidtis JJ. Evaluation of the AIDS dementia complex in clinical trials. J Acquir Immune Defic Syndr. 1990; 3 Suppl 2:S51-60. PMID: 2231303.
      View in: PubMed
    146. Rosenblum M, Scheck AC, Cronin K, Brew BJ, Khan A, Paul M, Price R. Dissociation of AIDS-related vacuolar myelopathy and productive HIV-1 infection of the spinal cord. Neurology. 1989 Jul; 39(7):892-6. PMID: 2739916.
      View in: PubMed
    147. Brew BJ, Bhalla RB, Fleisher M, Paul M, Khan A, Schwartz MK, Price R. Cerebrospinal fluid beta 2 microglobulin in patients infected with human immunodeficiency virus. Neurology. 1989 Jun; 39(6):830-4. PMID: 2657485.
      View in: PubMed
    148. Janssen RS, Cornblath DR, Epstein LG, McArthur J, Price RW. Human immunodeficiency virus (HIV) infection and the nervous system: report from the American Academy of Neurology AIDS Task Force. Neurology. 1989 Jan; 39(1):119-22. PMID: 2642609.
      View in: PubMed
    149. Brew BJ, Rosenblum M, Price R. AIDS dementia complex and primary HIV brain infection. J Neuroimmunol. 1988 Dec; 20(2-3):133-40. PMID: 3058741.
      View in: PubMed
    150. Price R, Brew BJ. The AIDS dementia complex. J Infect Dis. 1988 Nov; 158(5):1079-83. PMID: 3053922.
      View in: PubMed
    151. Brew BJ, Sidtis JJ, Rosenblum M, Price RW. AIDS dementia complex. J R Coll Physicians Lond. 1988 Jul; 22(3):140-4. PMID: 3411540.
      View in: PubMed
    152. Price R, Brew B. Management of the neurologic complications of HIV infection and AIDS. Infect Dis Clin North Am. 1988 Jun; 2(2):359-72. PMID: 2849620.
      View in: PubMed
    153. Brew BJ, Price R. Another retroviral disease of the nervous system: chronic progressive myelopathy due to HTLV-1. N Engl J Med. 1988 May 5; 318(18):1195-7. PMID: 2896301.
      View in: PubMed
    154. Tross S, Price R, Navia B, Thaler HT, Gold J, Hirsch DA, Sidtis JJ. Neuropsychological characterization of the AIDS dementia complex: a preliminary report. AIDS. 1988 Apr; 2(2):81-8. PMID: 3132951.
      View in: PubMed
    155. Price RW, Brew B, Sidtis J, Rosenblum M, Scheck AC, Cleary P. The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science. 1988 Feb 5; 239(4840):586-92. PMID: 3277272.
      View in: PubMed
    156. Aronow HA, Brew BJ, Price R. The management of the neurological complications of HIV infection and AIDS. AIDS. 1988; 2 Suppl 1:S151-9. PMID: 3147665.
      View in: PubMed
    157. Price R, Brew B. Infection of the central nervous system by human immunodeficiency virus. Role of the immune system in pathogenesis. Ann N Y Acad Sci. 1988; 540:162-75. PMID: 3061334.
      View in: PubMed
    158. Brew BJ, Rosenblum M, Price RW. Pathogenetic implications of neuropathological findings in the AIDS dementia complex. Psychopharmacol Bull. 1988; 24(3):307-10. PMID: 3153483.
      View in: PubMed
    159. Rottenberg DA, Moeller JR, Strother SC, Sidtis JJ, Navia BA, Dhawan V, Ginos JZ, Price RW. The metabolic pathology of the AIDS dementia complex. Ann Neurol. 1987 Dec; 22(6):700-6. PMID: 3501695.
      View in: PubMed
    160. Pumarola-Sune T, Navia BA, Cordon-Cardo C, Cho ES, Price RW. HIV antigen in the brains of patients with the AIDS dementia complex. Ann Neurol. 1987 May; 21(5):490-6. PMID: 3296948.
      View in: PubMed
    161. Navia BA, Price RW. The acquired immunodeficiency syndrome dementia complex as the presenting or sole manifestation of human immunodeficiency virus infection. Arch Neurol. 1987 Jan; 44(1):65-9. PMID: 3800724.
      View in: PubMed
    162. Huang JT, Schinazi RF, Gadler H, Price RW, Su TL, Watanabe KA. 5-substituted 2'-fluoro-arabinonucleosides as potential antiviral agents. Nucleic Acids Symp Ser. 1987; (18):261-4. PMID: 2827131.
      View in: PubMed
    163. Petito CK, Cho ES, Lemann W, Navia BA, Price R. Neuropathology of acquired immunodeficiency syndrome (AIDS): an autopsy review. J Neuropathol Exp Neurol. 1986 Nov; 45(6):635-46. PMID: 3021914.
      View in: PubMed
    164. Doro S, Navia BA, Kahn A, Pumarola-Sune T, Price R. Confirmation of HTLV-III virus in cornea. Am J Ophthalmol. 1986 Sep 15; 102(3):390-1. PMID: 3019144.
      View in: PubMed
    165. Navia BA, Jordan BD, Price RW. The AIDS dementia complex: I. Clinical features. Ann Neurol. 1986 Jun; 19(6):517-24. PMID: 3729308.
      View in: PubMed
    166. Navia BA, Cho ES, Petito CK, Price R. The AIDS dementia complex: II. Neuropathology. Ann Neurol. 1986 Jun; 19(6):525-35. PMID: 3014994.
      View in: PubMed
    167. Navia BA, Petito CK, Gold JW, Cho ES, Jordan BD, Price RW. Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: clinical and neuropathological findings in 27 patients. Ann Neurol. 1986 Mar; 19(3):224-38. PMID: 3963767.
      View in: PubMed
    168. Price R, Navia BA, Cho ES. AIDS encephalopathy. Neurol Clin. 1986 Feb; 4(1):285-301. PMID: 2425241.
      View in: PubMed
    169. Petito CK, Navia BA, Cho ES, Jordan BD, George DC, Price RW. Vacuolar myelopathy pathologically resembling subacute combined degeneration in patients with the acquired immunodeficiency syndrome. N Engl J Med. 1985 Apr 4; 312(14):874-9. PMID: 3974673.
      View in: PubMed
    170. Shaw GM, Harper ME, Hahn BH, Epstein LG, Gajdusek DC, Price RW, Navia BA, Petito CK, O'Hara CJ, Groopman JE. HTLV-III infection in brains of children and adults with AIDS encephalopathy. Science. 1985 Jan 11; 227(4683):177-82. PMID: 2981429.
      View in: PubMed
    171. Jordan BD, Navia BA, Petito C, Cho ES, Price RW. Neurological syndromes complicating AIDS. Front Radiat Ther Oncol. 1985; 19:82-7. PMID: 3979830.
      View in: PubMed
    172. Saito Y, Price RW. Enhanced regional uptake of 2-deoxy-D-[14C]glucose in focal herpes simplex type 1 encephalitis: autoradiographic study in the rat. Neurology. 1984 Mar; 34(3):276-84. PMID: 6538267.
      View in: PubMed
    173. Epstein LG, Sharer LR, Cho ES, Myenhofer M, Navia B, Price RW. HTLV-III/LAV-like retrovirus particles in the brains of patients with AIDS encephalopathy. AIDS Res. 1984-1985; 1(6):447-54. PMID: 6100783.
      View in: PubMed
    174. Price RW, Nielsen S, Horten B, Rubino M, Padgett B, Walker D. Progressive multifocal leukoencephalopathy: a burnt-out case. Ann Neurol. 1983 May; 13(5):485-90. PMID: 6307116.
      View in: PubMed
    175. Tsukamoto LF, Price RW. Interferon protects neurons in culture infected with vesicular stomatitis and herpes simplex viruses. J Neurol Sci. 1982 Oct; 56(1):115-28. PMID: 6183402.
      View in: PubMed
    176. Willoughby E, Price RW, Padgett BL, Walker DL, Dupont B. Progressive multifocal leukoencephalopathy (PML): in vitro cell-mediated immune responses to mitogens and JC virus. Neurology. 1980 Mar; 30(3):256-62. PMID: 6987549.
      View in: PubMed
    177. Price R, Schmitz J. Reactivation of latent herpes simplex virus infection of the autonomic nervous system by postganglionic neurectomy. Infect Immun. 1978 Feb; 19(2):523-32. PMID: 204579; PMCID: PMC414115.
    178. Walz MA, Price R, Hayashi K, Katz BJ, Notkins AL. Effect of immunization on acute and latent infections of vaginouterine tissue with herpes simplex virus types 1 and 2. J Infect Dis. 1977 May; 135(5):744-52. PMID: 192810.
      View in: PubMed
    179. Price R. Viral infections of the autonomic nervous system and its target organs: pathogenetic mechanisms. Med Hypotheses. 1977 Jan-Feb; 3(1):33-6. PMID: 192985.
      View in: PubMed
    180. Walz MA, Price RW, Notkins AL. Latent ganglionic infection with herpes simplex virus types 1 and 2: viral reactivation in vivo after neurectomy. Science. 1974 Jun 14; 184(4142):1185-7. PMID: 4364361.
      View in: PubMed
    Richard's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _
    Back to TOP